Disruption of these interactions could therefore affect the ability of cMyBP-C to activate the thin filament or to stabilize the super-relaxed (SRX) state of myosin44–46, either of which would be expected to directly cause contraction or relaxation abnormalities resulting in a cardiomyopathy. The gene discussed is MYBPC3; the disease is cardiomyopathy.